Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in Cancer Treatment : From Systemic Chemotherapy to Targeted Therapy / / by Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares
| Advances in Cancer Treatment : From Systemic Chemotherapy to Targeted Therapy / / by Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares |
| Autore | Cavalcanti Iago Dillion Lima |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
| Descrizione fisica | 1 online resource (VIII, 109 p. 27 illus., 25 illus. in color.) |
| Disciplina | 616.994 |
| Soggetto topico |
Oncology
Internal medicine Pharmacy Cancer—Treatment Tumor markers Cancer Nanomedicine Internal Medicine Cancer Therapy Tumour Biomarkers Cancer Nanotechnology Oncologia Terapèutica Fisiologia patològica Nanomedicina |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-68334-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Cancer: concepts and epidemiology -- A brief history of cancer -- What is Cancer? -- Cancer Epidemiology -- Cancer development and immunology -- Cell cycle -- Cell cycle control: the function of cyclins -- Cancer triggering agents -- Proto-oncogenes -- Tumor suppressor genes -- Development of tumor mass -- Cancer Immunology -- Discovery of tumor markers -- Cancer diagnosis -- Impact of the discovery of tumor markers -- Main tumor markers for cancer diagnosis -- Alpha-fetoprotein (AFP) -- Human Chorionic Gonadotropin (β-HCG) -- Mucin-like cancer-associated antigen (MCA) -- CA 15.3 -- Carcinoembryonic antigen (CEA) -- Bladder tumor antigen (BTA) -- Telomerase -- Nuclear matrix protein (NMP 22) -- Cyfra 21.1 -- Prostatic acid phosphatase (PAP) -- Prostate-specific antigen (PSA) -- CA 125 -- CA 19.9 -- p53 -- CA 72.4 -- K-ras -- HER2 -- Cancer staging -- Conventional cancer treatment -- Therapeutic modalities of cancer -- Surgery -- Radiotherapy -- Antineoplastic chemotherapy -- Classification of antineoplastic agents by cycle -- Specific cycle antineoplastics -- Nonspecific antineoplastic agents -- Classification of antineoplastic agents by chemical structure and function -- Alkylating agents -- Antimetabolites -- Plant-derived antineoplastics -- Antitumor antibiotics -- Chemotherapy toxicity -- Hematological toxicity -- Liver toxicity -- Cardiac toxicity -- Anthracyclines -- Fluoropyrimidine -- Taxanes -- Pulmonary toxicity -- Neurological toxicity -- Renal toxicity -- Gastrointestinal toxicity -- Metabolic changes -- Targeted therapies in cancer treatment -- Overexpressed receptors on tumor cells -- Immunotherapy -- Monoclonal antibodies -- Types of monoclonal antibodies -- Side effects of monoclonal antibodies -- Checkpoint Inhibitors -- Side effects of checkpoint inhibitors -- Cancer Vaccines -- Vaccines in cancer prevention -- Vaccines for the treatment of cancer -- Non-specific immunotherapies -- Tyrosine kinase inhibitors -- Imatinib -- Gefitinib -- Erlotinib -- Sorafenib -- Dasatinib -- Nilotinib -- Lapatinib -- Adverse events of tyrosine kinase inhibitors -- Conventional chemotherapy vs. targeted therapy -- Differences between conventional chemotherapy and targeted therapy -- Risks and benefits of conventional chemotherapy compared to targeted therapy -- Eligibility criteria for the indication of the targeted therapy -- Side effects of targeted therapy -- Can targeted therapy replace conventional chemotherapy? -- Targeted therapy associated with conventional chemotherapy -- Pharmaceutical nanotechnology applied to cancer -- Pharmaceutical nanotechnology -- Classification of nanosystems -- Liposomes -- Micelles -- Polymeric nanoparticles -- Solid lipid nanoparticles -- Magnetic nanoparticles -- Metal nanoparticles -- Main functions of nanosystems in cancer -- Pharmaceutical nanotechnology in cancer diagnosis -- Pharmaceutical nanotechnology for cancer treatment. |
| Record Nr. | UNINA-9910484989203321 |
Cavalcanti Iago Dillion Lima
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Alginate biomaterial : drug delivery strategies and biomedical engineering / / edited by Sougata Jana, Subrata Jana
| Alginate biomaterial : drug delivery strategies and biomedical engineering / / edited by Sougata Jana, Subrata Jana |
| Edizione | [First edition 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (420 pages) |
| Disciplina | 572.566 |
| Soggetto topico |
Drug delivery systems
Biomaterials Therapeutics Biology—Technique Genetic engineering Cancer—Treatment Biomedical engineering Alginates Drug Delivery Systems Nanoparticle Drug Delivery System Biomedical Engineering Neoplasm - therapy Gene Transfer Techniques Tissue Scaffolds Drug Delivery Gene Delivery Cancer Therapy Biomedical Engineering and Bioengineering |
| ISBN | 981-19-6937-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. ALGINATE BASED MATRIX TABLET FOR DRUG DELIVERY -- Chapter 2. Alginate based micro particulate systems for drug delivery -- Chapter 3. Alginate based nanocarriers for controlled drug delivery applications -- Chapter 4. Alginate based carriers for topical drug delivery -- Chapter 5. Alginate based Hydrogel in drug delivery and biomedical applications -- Chapter 6. Alginate based interpenetrating polymer network (IPN) in drug delivery and biomedical applications -- Chapter 7. Alginate based micelle in biomedical applications -- Chapter 8. Alginate based polyelectrolyte complexes for drug delivery and biomedical applications -- Chapter 9. Alginate-Based Inhalable Particles for Controlled Pulmonary Drug Delivery -- Chapter 10. Biomedical Applications of Alginate in the Delivery System for Natural Products -- Chapter 11. Alginate in cancer therapy -- Chapter 12. Alginate carriers in wound healing applications -- Chapter 13. Alginate as support material in enzyme Immobilization -- Chapter 14. Alginate in Gene and Vaccine Delivery -- Chapter 15. Alginate based scaffolds in Tissue engineering and Regenerative Medicine. |
| Record Nr. | UNINA-9910647780303321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Artificial Intelligence and Precision Oncology : Bridging Cancer Research and Clinical Decision Support / / edited by Zodwa Dlamini
| Artificial Intelligence and Precision Oncology : Bridging Cancer Research and Clinical Decision Support / / edited by Zodwa Dlamini |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (317 pages) |
| Disciplina | 610.28563 |
| Soggetto topico |
Cancer
Oncology Medical screening Cancer—Treatment Tumor markers Artificial Intelligence Precision Medicine Neoplasms - therapy Epigenomics Drug Design Biomarkers, Tumor Cancer Biology Cancer Screening Cancer Therapy Tumour Biomarkers |
| ISBN |
9783031215063
9783031215056 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction: The Application of AI in Precision Oncology: Tailoring Diagnosis, Treatment, and the Monitoring of Disease Progression to the Patient -- Part I. Artificial Intelligence for Screening, Diagnosis, Monitoring in Precision Oncology -- Chapter 2. Application of AI in Novel Biomarkers Detection that Induce Drug Resistance, Enhance Treatment Regimens and Advancing Precision Oncology -- Chapter 3. Use of Artificial Intelligence in Implementing Mainstream Precision Medicine to Improve Traditional Symptom-driven Practice of Medicine: Allowing Early Interventions and Tailoring better-personalized Cancer Treatments -- Chapter 4. AI as a Novel Approach for Exploring ccfNAs in Personalized Clinical Diagnosis and Prognosis: Providing Insight into the Decision-Making in Precision Oncology -- Chapter 5. AI-Enhanced Digital Pathology and Radiogenomics in Precision Oncology -- Part II. Artificial Intelligence and Omics in Precision Oncology -- Chapter 6. Epigenetics Analysis Using Artificial Intelligence in the Era of Precision Oncology -- Chapter 7. Association of Metabolomics with AI in Precision Oncology: Emerging Perspectives for More Effective Cancer Care -- Chapter 8. Artificial Intelligence Application to Microbiomics Data for Improved Clinical Decision Making in Precision Oncology -- Part III. Artificial Intelligence in Cancer Therapy and the Clinical Applications -- Chapter 9. AI and Nanotechnology in Realizing the Goal of Precision Medicine: Tailoring the Best Treatment for Personalized Cancer Treatment -- Chapter 10. Artificial Intelligence-Based Medical Devices Revolution in Cancer Screening: Impact into Clinical Practice -- Chapter 11. Intelligent Drug Design and Use for Cancer Treatment: The Roles of AI and Precision Oncology in Targeting Patient-Specific Splicing Profiles -- Chapter 12. Applying Artificial Intelligence Prediction Tools for Advancing Precision Oncology in Immunotherapy: Future Perspectives in Personalized Care -- Chapter 13. Employing AI-Powered Decision Support Systems in Recommending the Most Effective Therapeutic Approaches for Individual Cancer Patients: Maximizing Therapeutic Efficacy -- Chapter 14. AI-Pathway Companion in Clinical Decision Support: Enabling Personalized and Standardized Care Along Care Pathways in Oncology -- Chapter 15. AI Tools Offering Cancer Clinical Applications for Risk Predictor, Early Detection, Diagnosis, and Accurate Prognosis: Perspectives in Personalised Care -- Chapter 16. Conclusion and Insights into the Future of AI in Precision Oncology. |
| Record Nr. | UNINA-9910739486103321 |
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma : Glissonean Pedicle Approach / / edited by Jiangsheng Huang, Xianling Liu, Jixiong Hu
| Atlas of Anatomic Hepatic Resection for Hepatocellular Carcinoma : Glissonean Pedicle Approach / / edited by Jiangsheng Huang, Xianling Liu, Jixiong Hu |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (339 pages) |
| Disciplina | 616.99436 |
| Soggetto topico |
Cancer—Treatment
Surgery Cancer Therapy General Surgery |
| ISBN | 981-13-0668-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Clinical Anatomy of the Liver -- Preoperative Preparation for Patients with Hepatocellular Carcinoma -- Basic Techniques for Hepatic Resection by the Glissonean Approach -- Types of Segments-Oriented Hepatic Resection by the Glissonean Pedicle Approach -- Other Types of Hepatic Resection for HCC. |
| Record Nr. | UNINA-9910383659403321 |
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Research: An Interdisciplinary Approach / / edited by Nima Rezaei
| Cancer Research: An Interdisciplinary Approach / / edited by Nima Rezaei |
| Autore | Rezaei Nima |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (614 pages) |
| Disciplina | 616.9940072 |
| Collana | Interdisciplinary Cancer Research |
| Soggetto topico |
Cancer
Cancer—Treatment Stem cells Cytology Medical genetics Immunology Cancer Biology Cancer Therapy Cancer Stem Cells Cell Biology Medical Genetics |
| ISBN | 3-031-32458-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Interdisciplinary Approaches in Cancer Research -- Role of Immune Cells in the Tumor Microenvironment -- Spatial Transcriptomic Approaches for Understanding the Tumor Microenvironment (TME) -- Role of Mesenchymal Stem/Stromal Cells in Cancer Development -- Cancer-associated Fibroblasts and Their Role in Cancer Progression -- The Role of Tumoroids in Cancer Research -- Myokines Expression in Cancer Cachexia -- Epigenetics in Cancer Biology -- Epigenetic Regulation of Cancer by Natural Touch: Phytochemicals and Epigenetic Regulation -- Telomerase Reverse Transcriptase in Humans: From Biology to Cancer Immunity -- Molecular Mechanisms of Metal-induced Carcinogenesis -- Epi-drugs Targeting RNA Dynamics in Cancer -- Oncologic Emergencies: Pathophysiology, Diagnosis, and Initial Management -- Malignancies in Inborn Errors of Immunity -- Hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity and Malignancy -- Personalized Immuno-oncology with Immunodeficiency Mouse Models -- Allergy and Cancer: New Perspectives -- Depression and Cancer: the Inflammatory Bridge -- Impact of Cancer-Related Sarcopenia on Systemic Immune Status -- Surveillance of Subclinical Cardiovascular Complications in Childhood Cancer Survivors: Exercise as a Diagnostic and Therapeutic Modality. |
| Record Nr. | UNINA-9910734848103321 |
|
Rezaei Nima
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Stem Cells: Basic Concept and Therapeutic Implications / / edited by Farhadul Islam, Alfred K. Lam
| Cancer Stem Cells: Basic Concept and Therapeutic Implications / / edited by Farhadul Islam, Alfred K. Lam |
| Autore | Islam Farhadul |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (375 pages) |
| Disciplina | 616.99407 |
| Altri autori (Persone) | LamAlfred K |
| Soggetto topico |
Cancer
Stem cells Cancer—Treatment Cancer—Genetic aspects Cancer Stem Cells Cancer Therapy Cancer Biology Cancer Genetics and Genomics |
| ISBN | 981-9931-85-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction and perspective in carcinogenesis -- 2. Origin and Development of Cancer Stem Cells -- 3. Detection and Isolation of Cancer Stem Cells -- 4. The genetic and epigenetic landscape of cancer stem cells -- 5. Metabolism of Cancer Stem Cell -- 6. Plasticity of Cancer Stem Cell -- 7. Cancer Stem Cells in Cancer Initiation and Progression -- 8. Cancer Stem Cells and Metastasis -- 9. Roles of Cancer Stem Cells in Therapy resistance and Disease Recurrence -- 10. Novel therapeutics targeting cancer stem cell surface markers -- 11. Therapeutics targeting cancer stem cells signalling pathways -- 12. Cancer stem cells therapeutics delivery and EPR effect -- 13. Immunotherapy against cancer stem cells -- 14. Engineering nanobody targeting cancer stem cells -- 15. Biological barriers for drug delivery to cancer stem cells -- 16. Cancer Stem Cell Markers in Haematological Malignancies -- 17. Diagnostic and Prognostic Significance of Cancer Stem Cells Surface Markers -- 18. Diagnostic and prognostic implications of cancer stem cells transcription factors -- 19. Diagnostic and prognostic significance of intracellular markers of CSCs in patients with cancers. . |
| Record Nr. | UNINA-9910736002703321 |
|
Islam Farhadul
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Circulating Tumor Cells : Advances in Liquid Biopsy Technologies / / edited by Richard J. Cote, Evi Lianidou
| Circulating Tumor Cells : Advances in Liquid Biopsy Technologies / / edited by Richard J. Cote, Evi Lianidou |
| Autore | Cote Richard J |
| Edizione | [2nd ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (672 pages) |
| Disciplina | 616.994075 |
| Altri autori (Persone) | LianidouEvi |
| Collana | Current Cancer Research |
| Soggetto topico |
Cancer
Cancer—Treatment Tumor markers Cancer Biology Cancer Therapy Tumour Biomarkers |
| ISBN | 3-031-22903-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1. CTC Technologies -- Affinity -- Physical -- ctDNA -- miRNA -- Exosomes -- Part 2 -- Biology of CTC -- Dormancy -- Culture -- EMT -- ctDNA and Exosomes -- Cells in circulation with CTC -- Part 3 -- CTC Analysis -- IHC, FISH, and other molecular assays -- Functional characterization -- Advanced microscopy and AI -- Analysis of non-cellular circulating markers -- Part 4 -- Clinical Applications of the Liquid Biopsy -- Early detection and cancer screening -- Prognosis and therapeutic monitoring -- Applications in Clinical Trials -- Applications in Drug Development. |
| Record Nr. | UNINA-9910736978503321 |
|
Cote Richard J
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evolutionary Dynamics of Malignancy : The Genetic and Environmental Causes of Cancer / / by Robert C. Jackson
| Evolutionary Dynamics of Malignancy : The Genetic and Environmental Causes of Cancer / / by Robert C. Jackson |
| Autore | Jackson Robert C |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (271 pages) |
| Disciplina | 616.994042 |
| Soggetto topico |
Cancer
Cancer—Animal models Cancer—Treatment Cancer—Genetic aspects Cancer Biology Cancer Models Cancer Therapy Cancer Genetics and Genomics Cancer Microenvironment |
| ISBN | 3-031-32573-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Cancer as a Disease of Cell Proliferation -- Chapter 2: Genetic and Chromosomal Instability -- Chapter 3: Cancer as a Disease of Defective Cell Cycle Checkpoint Function -- Chapter 4: The DNA Damage Checkpoint -- Chapter 5: Dynamics of the Spindle Assembly Checkpoint -- Chapter 6: Cancer as a Disease of Complexity: The Dynamics of Drug Resistance -- Chapter 7: Chronic Myeloid Leukaemia: a One-Hit Malignancy -- Chapter 8: Chronic Myelomonocytic Leukaemia: a Three-Hit Malignancy -- Chapter 9: The Cancer Stem Cell and Tumour Progression -- Chapter 10: Evading the antitumour immune response -- Chapter 11: Implications of Evolutionary Dynamics for Cancer Treatment and Prevention -- Chapter 12: In science, all conclusions are provisional. |
| Record Nr. | UNINA-9910734821703321 |
|
Jackson Robert C
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Genetics and Epigenetics of Breast Cancer / / by Madhumita Roy, Jaydip Biswas, Amitava Datta
| Genetics and Epigenetics of Breast Cancer / / by Madhumita Roy, Jaydip Biswas, Amitava Datta |
| Autore | Roy Madhumita |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource : illustrations |
| Disciplina | 616.99449042 |
| Soggetto topico |
Cancer
Cancer—Genetic aspects Cancer—Treatment Cancer Biology Cancer Genetics and Genomics Cancer Therapy |
| ISBN | 981-19-9925-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Breast cancer -- Chapter 1.1. Epidemiology -- Chapter 1.2. Etiology -- Chapter 1.3. Types of breast cancer -- Chapter 1.4. Signs and symptoms -- Chapter 1.5. Stages -- Chapter 1.6. Diagnosis -- Chapter 1.7. Treatment -- Chapter 2. Genetic landscape of breast carcinogenesis -- Chapter 2.1. Hormone receptor positive breast cancer -- Chapter 2.1. Her2 positive breast cancer -- Chapter 2.2. Triple negative breast cancer -- Chapter 3. Epigenetic involvement in breast carcinogenesis -- Chapter 3.1. Histone modification -- Chapter 3.2. DNA methylation -- Chapter 3.3. miRNA -- Chapter 4. Breast cancer control -- Chapter 4.1. Conventional drugs targeting Genetic and Epigenetics in Breast cancer -- Chapter 4.2. Pitfalls of conventional therapy -- Chapter 4.3. Natural remediation -- Chapter 5. Conclusion. |
| Record Nr. | UNINA-9910726293803321 |
|
Roy Madhumita
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Polymeric nanoparticles for the treatment of solid tumors / / edited by Santwana Padhi, Anindita Behera, Eric Lichtfouse
| Polymeric nanoparticles for the treatment of solid tumors / / edited by Santwana Padhi, Anindita Behera, Eric Lichtfouse |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (515 pages) |
| Disciplina | 616.99406 |
| Collana | Environmental Chemistry for a Sustainable World |
| Soggetto topico |
Medicine—Research
Biology—Research Nanotechnology Cancer—Treatment Biomedical Research Cancer Therapy Nanopartícules Càncer Terapèutica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-14848-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. The tumor microenvironment -- Chapter 2. Methods of formulation of polymeric nanoparticles -- Chapter 3. Natural polymers based nanoparticles targeted to solid tumors -- Chapter 4. Optimization of physicochemical properties of polymeric nanoparticles for targeting solid tumors -- Chapter 5. Passive and active targeting approaches for solid tumors -- Chapter 6. Polymeric nanoparticles entrapping natural drugs for cancer therapy -- Chapter 7. Polymeric nanoparticles entrapping drug combinations targeted to solid tumors -- Chapter 8. Ligands specific to over-expressed receptors in solid tumors -- Chapter 9. Ligand targeted polymeric nanoparticles for cancer chemotherapy -- Chapter 10. Polymeric nanoparticles as theranostics for targeting solid tumors -- Chapter 11. Oral delivery of polymeric nanoparticles for solid tumors -- Chapter 12. Polymeric nanoparticles to target glioblastoma tumors -- Chapter 13. Polymeric nanoparticles to target lung cancer -- Chapter 14. Polymer based nanoplatforms for targeting breast cancer -- Chapter 15. PH-Sensitive polymeric nanoparticles for cancer treatment -- Chapter 16. Polymeric nanoplatforms for targeted treatment of prostate cancer -- Chapter 17. Cellular internalization and toxicity of polymeric nanoparticles -- Chapter 18. Prospects and challenges in the treatment of solid tumors. |
| Record Nr. | UNINA-9910631081103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
- Cancer Therapy (11)
-
Cancer—Treatment
(11)
- Cancer (7)
- Cancer Biology (6)
- Cancer Genetics and Genomics (3)